Common Contracts
7 similar Purchase Agreement contracts by AtriCure, Inc., Natus Medical Inc, Derma Sciences, Inc., others
4,250,000 Shares1 ATRICURE, INC. Common Stock PURCHASE AGREEMENTPurchase Agreement • February 13th, 2014 • AtriCure, Inc. • Surgical & medical instruments & apparatus • New York
AtriCure, Inc., a Delaware corporation (the “Company”), and the stockholders of the Company listed in Schedule I hereto (the “Selling Stockholders”) severally propose to sell to the several underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of 4,250,000 shares (the “Firm Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The Firm Shares consist of 3,023,025 authorized but unissued shares of Common Stock to be issued and sold by the Company and 1,226,975 outstanding shares of Common Stock to be sold by the Selling Stockholders. The Company has also granted to the several Underwriters an option to purchase up to 637,500 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
ATRICURE, INC. Common Stock PURCHASE AGREEMENTPurchase Agreement • January 16th, 2013 • AtriCure, Inc. • Surgical & medical instruments & apparatus • New York
AtriCure, Inc., a Delaware corporation (the “Company”), proposes to sell to Piper Jaffray & Co. (the “Underwriter”) an aggregate of 3,475,000 shares (the “Firm Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the Underwriter an option to purchase up to an aggregate of 521,250 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
3,042,000 Shares MAKO Surgical Corp. Common Stock PURCHASE AGREEMENTPurchase Agreement • November 15th, 2012 • MAKO Surgical Corp. • Orthopedic, prosthetic & surgical appliances & supplies • New York
MAKO Surgical Corp., a Delaware corporation (the “Company”), proposes to sell to Piper Jaffray & Co. (the “Underwriter”) an aggregate of 3,042,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the Underwriter an option to purchase up to 456,300 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
2,125,000 Shares DERMA SCIENCES, INC. Common Stock PURCHASE AGREEMENTPurchase Agreement • April 4th, 2012 • Derma Sciences, Inc. • Surgical & medical instruments & apparatus • New York
Derma Sciences, Inc., a Pennsylvania corporation (the “Company”), proposes to sell to you as underwriter (the “Underwriter”), an aggregate of 2,125,000 shares (the “Securities”) of common stock, $0.01 par value per share (the “Common Stock”), of the Company.
4,700,000 Shares1 NANOSPHERE, INC. Common Stock PURCHASE AGREEMENTPurchase Agreement • October 21st, 2009 • Nanosphere Inc • Surgical & medical instruments & apparatus • New York
Nanosphere, Inc., a Delaware corporation (the “Company”), proposes to sell you, as underwriter (the “Underwriter”), an aggregate of 4,700,000 shares (the “Firm Shares”) of Common Stock, $0.01 par value per share (the “Common Stock”), of the Company. The Company has also granted to the Underwriter an option to purchase up to 705,000 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Agreement are herein collectively called the “Securities.”
770,000 Shares NATUS MEDICAL INCORPORATED Common Stock PURCHASE AGREEMENTPurchase Agreement • April 4th, 2008 • Natus Medical Inc • Electromedical & electrotherapeutic apparatus • California
Natus Medical Incorporated, a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) an aggregate of 770,000 authorized but unissued shares (the “Securities”) of Common Stock, $.001 par value per share (the “Common Stock”), of the Company.
2,300,000 Shares NATUS MEDICAL INCORPORATED Common Stock PURCHASE AGREEMENTPurchase Agreement • August 18th, 2006 • Natus Medical Inc • Electromedical & electrotherapeutic apparatus • California
Natus Medical Incorporated, a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) an aggregate of 2,300,000 authorized but unissued shares (the “Securities”) of Common Stock, $.001 par value per share (the “Common Stock”), of the Company.
